Fig. 5From: Effectiveness of a treat-to-target strategy in patients with moderate to severely active rheumatoid arthritis treated with abataceptMean number of changes in rheumatoid arthritis (RA) treatment through 1 year. At months 3, 6, 9, and 12, T2T sample size was 106, 93, 87, and 86, and RC sample size was 138, 136, 125, and 123, respectively. CI: confidence interval; RARC: routine care; T2T: treat-to-targetBack to article page